ORBIMED ADVISORS LLC – ALX Oncology Holdings Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$27.47M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+18.29%
quarter
ALX Oncology Holdings Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +31.32% | 684.73K shares | 9.78M | $9.57 | 2.87M |
Q2 2022 | share | Increase | +251.66% | 1.56M shares | 7.18M | $8.09 | 2.18M |
Q1 2022 | share | Increase | +199.47% | 414.1K shares | 6.04M | $16.9 | 621.7K |
Q4 2021 | share | Increase | +38.40% | 57.6K shares | -6.61M | $21.93 | 207.6K |
Q3 2021 | share | 0.00% | 0 shares | 2.87M | $73.86 | 150K | |
Q2 2021 | share | 0.00% | 0 shares | -2.85M | $54.68 | 150K | |
Q1 2021 | share | 0.00% | 0 shares | -1.86M | $73.74 | 150K | |
Q4 2020 | share | Increase | 0.00% | 150K shares | 12.93M | $86.2 | 150K |